MedTrace Logo

SBI for PSM and PSD

NCT06923384 · Status: ENROLLING_BY_INVITATION · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2025-05-04

No results posted yet for this study

Summary

A pilot randomized controlled trial to assess the feasibility, acceptability, and impact of screening and brief intervention to address prescription stimulant misuse and diversion among college students.

Conditions

  • Prescription Stimulant Misuse
  • Prescription Stimulant Diversion

Interventions

BEHAVIORAL

F2F

After T1 assessment, students meet with a trained provider and receive prevention or brief intervention. Students then complete assessments at two additional times.

BEHAVIORAL

eSBI

After T1 assessment, students watch and respond to a prevention or brief intervention video series. Students then complete assessments at two additional times.

BEHAVIORAL

Control

Students complete the assessments at each time point, but do not receive any intervention or informational material.

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • California State University, Long Beach

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-10-01
Primary Completion
2025-08-11
Completion
2026-05-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06923384 on ClinicalTrials.gov